Showing results (41-50 of 237) with videos related to
Sort By:
Pageof 24
British Journal of Clinical Pharmacology|December 24, 2017
Population exposure-safety analysis of cediranib for Phase I and II studies in patients with cancerNidal Al-Huniti, Klas Petersson, Weifeng Tang, et al.Clinical Therapeutics|July 13, 2023
Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional ComparisonXiaoying Zhao, Rui Ning, Andrew Hui, et al.British Journal of Clinical Pharmacology|February 19, 2017
Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancerJianguo Li, Nidal Al-Huniti, Anja Henningsson, et al.Frontiers in Immunology|March 10, 2025
Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug productsHammodah R Alfar, Cecil Chen, Eric Lachacz, et al.British Journal of Clinical Pharmacology|October 23, 2021
Common UGT1A9 polymorphisms do not have a clinically meaningful impact on the apparent oral clearance of dapagliflozin in type 2 diabetes mellitusM Daniel Naagaard, Roy Chang, Mats Någård, et al.Bioscience Reports|December 6, 2019
Association between apurinic/apyrimidinic endonuclease 1 rs1760944 T>G polymorphism and susceptibility of cancer: a meta-analysis involving 21764 subjectsGuowen Ding, Yu Chen, Huiwen Pan, et al.Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|February 6, 2026
[Clinical and genetic analysis of a Chinese pedigree affected with Hereditary dentin dysplasia type II due to a variant of DSPP gene]Fang Li, Yingting Yang, Yang Liu, et al.International Journal of Clinical and Experimental Medicine|November 10, 2015
Polymorphisms in the intercellular adhesion molecule 1 gene and cancer risk: a meta-analysisWeifeng Tang, Yafeng Wang, Yuanmei Chen, et al.CPT: Pharmacometrics & Systems Pharmacology|January 13, 2021
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental ChangesHeeseung Jo, Venkatesh Pilla Reddy, Joanna Parkinson, et al.Journal of Cellular Biochemistry|October 19, 2018
Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma riskWeifeng Tang, Shuchen Chen, Jun Liu, et al.Pageof 24